China risks Analysts have also noted Arm's limited control over its China joint venture, Arm China, which contributes 24% of revenue. "Plus, Arm can only sell to China customers via the Arm China channel, and they can offer competing product. With no direct stake in Arm China, they currently have very little control over their only means to sell in China." Valuation Analysts at New Constructs have also challenged Arm's valuation. Growth Analysts at Bernstein were also cautious, while expecting cloud, automotive, and mobile royalties to drive healthy top-line growth for Arm.

---

Persons: Rohit Kulkarni, Roth, SoftBank, Bernstein, Sara Russo, Russo, it's, Timm Schulze, Schulze, Melander, — CNBC's Michael Bloom Organizations: Apple, Nvidia, SoftBank Locations: British, New York, SoftBank, China, Arm China